ImmunoGen, Inc.
Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Cambridge, Massachusetts. (Nasdaq: IMGN)

Queries for www.immunogen.com

Query User
immunogen entered by user 1929762
immunogen entered by user ditto
immunogen entered by user ditto